CHRO — ChromoGenics AB Balance Sheet
0.000.00%
- SEK64.85m
- SEK85.06m
- SEK13.65m
Annual balance sheet for ChromoGenics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 24.9 | 93.4 | 18.9 | 24.1 | 7.93 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 15.8 | 7.75 | 13 | 9.29 | 6.48 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 50 | 111 | 45.7 | 46 | 29.8 |
Net Property, Plant And Equipment | 74.3 | 90.8 | 102 | 103 | 98.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 132 | 214 | 160 | 162 | 139 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 41.7 | 29.6 | 52.6 | 24.9 | 27.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 89.4 | 92.9 | 103 | 91 | 96.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 42.6 | 121 | 57.7 | 70.5 | 42.8 |
Total Liabilities & Shareholders' Equity | 132 | 214 | 160 | 162 | 139 |
Total Common Shares Outstanding |